There is no Press for this Ticker
Oxurion NV is a biopharmaceutical company. The company is focused on developing treatments to preserve vision for patients with diseases affecting the back of the eye. It has developed a diverse portfolio of disease-modifying drug candidates, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide. It owns the global rights to Jetrea (ocriplasmin), the pharmacological vitreolysis drug approved for the treatment of symptomatic vitreomacular adhesion (in the U.S.) and vitreomacular traction (outside the U.S.).

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TBGNFOxurion0%112.6M

Oxurion Company Questions & Answers

Q

How do I buy Oxurion (TBGNF) stock?

A

You can purchase shares of Oxurion (OTC: TBGNF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Oxurion's (TBGNF) main competitors?

A

There are no as such competitors for Oxurion.

Q

What is the target price for Oxurion?

A

The latest price target for Oxurion (OTC: TBGNF) was reported by Roth Capital on 2019-12-23. The analyst firm set a price target for 0.00 expecting TBGNF to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

How much is Oxurion (TBGNF) stock ?

A

The stock price for Oxurion (OTC: TBGNF) is $2.94 last updated Thu Apr 15 2021 15:06:07 GMT+0000 (Coordinated Universal Time).

Q

When is the next Oxurion (TBGNF) dividend?

A

There are no upcoming dividends for Oxurion.

Q

When is Oxurion (OTC:TBGNF) reporting earnings?

A

There are no earnings for Oxurion

Q

When is the upcoming split for TBGNF?

A

There is no upcoming split for Oxurion.